DNTH vs KO · rev $6.2M vs P/E 25, rev $47.94B
Dianthus Therapeutics Inc. (DNTH) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
DNTH currently screens at market cap $4.40B. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the DNTH and KO stock pages for the full models.
Not investment advice.